VRTX | INSM Message Board Posts

Insmed Incorporated

  INSM website

INSM   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board
Msg  48271 of 48665  at  10/21/2019 4:54:58 PM  by

brewcrew


VRTX

vrtx announces this and the stock pops! 27k people in the USA!

Oct 21 (Reuters) - The U.S. Food and Drug Administration said on Monday it had approved Vertex Pharmaceuticals Inc's three-drug combination for cystic fibrosis (CF), a rare genetic condition. Trikafta is the first approved treatment that is effective for patients 12 years and older, who have a genetic mutation which affects 90% of CF patients or roughly 27,000 people in the United States, the agency said.


     e-mail to a friend      printer-friendly     add to library      
| More
Recs: 0     Views: 205
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board

Replies
Msg # Subject Author Recs Date Posted
48272 Re: VRTX Cancerfighter21 0 10/21/2019 5:18:07 PM
48273 Re: VRTX LTHandy 0 10/21/2019 5:26:33 PM
48275 Re: VRTX insmhistorian 0 10/21/2019 7:20:52 PM


About Us  •  Contact Us  •  Follow Us on Twitter  •  Members Directory  •  Help Center  •  Advertise
Not a member yet? What are you waiting for? Create Account
Want to contribute? Support InvestorVillage by donating
© 2003-2019 Investorvillage.com. All rights reserved. User Agreement
   
Financial Market Data provided by
.


Loading...